JAMA Network
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
JAMA Network
Apr 18, 2024, 15:10 |
Blog
Akash Maniam: New publication in JAMA Network Open - Neoadjuvant Chemoimmunotherapy in early stage NSLC
Akash Maniam, Clinical Director at Caribbean Cancer Research Institute, shared on Linkedin: “New publication in…
Jan 17, 2024, 17:15 |
Blog
Perry Wilson: Does it seem like your hospital patients are getting more... complicated?
Perry Wilson, Director, Clinical and Translational Research Accelerator at Yale University, shared on X/Twitter: "Does…
Dec 29, 2023, 05:08 |
Blog
Vivek Subbiah: 1 in 3 academic physicians report they are considering leaving their institution within 2 years
Vivek Subbiah shared a post on X/Twitter: ''1 in 3 academic physicians report they are…
Dec 24, 2023, 18:05 |
Insight
Marco Donia: Adjuvant Anti-PD-1 Immunotherapy for Resected Melanoma: Update December 2023
Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn:…
All:
4
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube